Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions
NCT ID: NCT00581659
Last Updated: 2017-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2007-11-30
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aims of this study are to determine the differences between B\&L PureVision™ aspheric contact lenses and a conventional spherical contact lens in visual performance measures associated with driving, such as number of objects seen.
The secondary aims of this study are to determine differences between B\&L PureVision™ aspheric contact lenses and a conventional spherical contact lens in driving performance measures such as number of objects hit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
NCT00985231
Evaluation of Two Different Designs of Bausch & Lomb Contact Lenses
NCT01118338
Comparative Performance of PureVision Lens Designs
NCT00661687
A Study to Evaluate the Performance of Two Designs of Soft Toric Lenses
NCT01309867
A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens
NCT01416142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a single-site study. Individuals who are currently spherical contact lens wearers, who believe they have little or no astigmatism, and who are licensed drivers will be invited to partipate in this study. Twenty-four completed subjects are required. This study will involve a 2x2 within-subject comparison.
The first independent variable is the contact lens. Each subject will wear both PureVision (TM0 aspheric contact lenses and conventional spherical contact lenses on separate visits. The second independent variable is visibility condition. Subjects will complete the study drive both in clear nighttime conditions and at night under glare conditions. In both cases, the driver will experience oncoming traffic; however, in the glare condition, the simulator will be equipped with a point light source sufficient to provide glare similar to that provided by oncoming traffic in the real world.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lens A, Lens B
The first independent variable is the contact lens. Each subject will wear both PureVision (TM0 aspheric contact lenses and conventional spherical contact lenses on separate visits. The second independent variable is visibility condition. Subjects will complete the study drive both in clear nighttime conditions and at night under glare conditions. In both cases, the driver will experience oncoming traffic; however, in the glare condition, the simulator will be equipped with a point light source sufficient to provide glare similar to that provided by oncoming traffic in the real world.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* drive at least 100 miles per month
* not restricted to driving at night
* willing to travel to the National Advanced Driving Simulator
* currently successfully wear soft spherical contact lenses
* between the ages of 25 and 45
* no previous participation in any vision simulator driving studies
Exclusion Criteria
* current serious illness or have received radiation and/or chemotherapy treatment within the last 6 months
* Type 1 Diabetics or Untreated Type II Diabetics
* current heart condition or heart attack, or pacemaker implanted within last 6 months
* known seizure disorder or epilepsy
* Meniere's disease or any inner ear, vertigo, hearing, or balance conditions
* known narcolepsy
* Chronic Fatigue Syndrome
* untreated sleep apnea
* uncontrolled asthma or chronic bronchitis
* Chronic Obstructive Pulmonary Disease
* migraine headaches that require narcotic medications
* untreated depression or anxiety disorder
* claustrophobia
* drug dependency
* untreated ADHD
* taking current prescription or over-the-counter medications that create sedation or drowsiness
* uncontrolled glaucoma or glaucoma under current treatment
* propensity toward motion sickness
* new diagnosis of dementia by physician
* diagnosis of macular degeneration
* experience any side effects from dilation of the eyes
* Diabetes-induced eye disease in either eye
* Cataract surgery in either eye or currently have cataracts
* refractive eye surgery in either eye
* more than 0.25 diopters of refractive astigmatism in either eye
* less than 0.05 microns of positive spherical aberration in either eye -refractive error less than -0.50 diopters or greater than -3.00 diopters -
25 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
University of Iowa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Timothy L. Brown
Associate Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Wilkinson, OD
Role: PRINCIPAL_INVESTIGATOR
National Advanced Driving Simulator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Advanced Driving Simulator
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200709761
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.